STAT Plus: Liquid biopsy startup Grail, in filing for IPO, lays out investments and plans for growth
MARK LENNIHAN/AP
The deep-pocketed startup Grail, which is hoping its blood test can detect cancer in healthy people, filed for an IPO.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario